Global Organ Transplant Diagnostics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Organ Transplant Diagnostics Market Research Report 2024
Demand for transplant diagnostic products is expected to increase, mainly due to factors such as increased public-private partnership funding for targeted research activities, increased burden of infectious diseases, increased number of transplant procedures, and technological advancements in the field of transplant diagnostics. The market segment by technology is divided into molecular and non-molecular analytical technologies. The field of molecular analysis technology has the largest market share. A large part of this part can be attributed to the benefits of molecular detection, such as short turnaround time, high program efficiency, research on multiple samples, and real-time sample analysis.
According to MRAResearch’s new survey, global Organ Transplant Diagnostics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Organ Transplant Diagnostics market research.
Key companies engaged in the Organ Transplant Diagnostics industry include QIAGEN NV, Thermo Fisher Scientific, BioMérieuxSA, CareDx, Luminex Corporation, Dickinson and Company and Biofortuna, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Organ Transplant Diagnostics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Organ Transplant Diagnostics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organ Transplant Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
QIAGEN NV
Thermo Fisher Scientific
BioMérieuxSA
CareDx
Luminex Corporation
Dickinson and Company
Biofortuna
Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies
Independent Reference Laboratories
Hospitals and Transplant Centers
Research Laboratories and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Organ Transplant Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Organ Transplant Diagnostics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Organ Transplant Diagnostics market research.
Key companies engaged in the Organ Transplant Diagnostics industry include QIAGEN NV, Thermo Fisher Scientific, BioMérieuxSA, CareDx, Luminex Corporation, Dickinson and Company and Biofortuna, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Organ Transplant Diagnostics were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Organ Transplant Diagnostics market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Organ Transplant Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
QIAGEN NV
Thermo Fisher Scientific
BioMérieuxSA
CareDx
Luminex Corporation
Dickinson and Company
Biofortuna
Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies
Segment by Application
Independent Reference Laboratories
Hospitals and Transplant Centers
Research Laboratories and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Organ Transplant Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source